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Abstract
Uncrossable lesions are those that cannot be crossed with a balloon after successful
guidewire crossing. These lesions are challenging and are commonly encountered in
tortuous and calcified arteries as well as chronic total occlusions. They are the second
most common barrier to successful PCI in CTO intervention after inability to cross
the CTO segment with a guidewire. Procedures involving balloon uncrossable lesions
during routine and CTO PCI utilise longer procedural times, radiation dose and con-
trast volumes with a lower likelihood of procedural success. In this article, we
describe a pragmatic approach of managing balloon uncrossable lesions utilising the
most contemporary equipment available in an algorithmic fashion beginning with sim-
ple, cost effective techniques right up to complex strategies for advanced operators.
In addition, some of these lesions, even when crossed by any technique, they may
remain difficult to dilate and prepare for stent insertion. We describe an approach of
how to manage these undilatable lesions.
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1 | INTRODUCTION
Uncrossable lesions are those that cannot be crossed with a balloon
after successful guidewire crossing. These lesions are challenging
and are commonly encountered in day-to-day PCI particularly in tor-
tuous and calcified arteries as well as chronic total occlusions (CTO).
Uncrossable lesions are encountered in up to 9% of all CTO inter-
ventions and are the second most common barrier to successful PCI
in CTO intervention after inability to cross the CTO segment with a
guidewire.1,2 Balloon uncrossable lesions encountered during CTO
PCI are more likely to be heavily calcified, tortuous and have higher
J-CTO scores.2 Procedures involving balloon uncrossable lesions
during routine and CTO PCI utilize longer procedural times, radiation
dose and contrast volumes with a lower likelihood of procedural
success.1
In this article, we describe a pragmatic approach of managing bal-
loon uncrossable lesions utilizing the most contemporary equipment
available in an algorithmic fashion beginning with simple, cost-
effective techniques right up to complex strategies for advanced
operators.
In addition, some of these lesions, even when crossed by any
technique, they may remain difficult to dilate and prepare for stent
insertion. We describe an approach of how to manage these
undilatable lesions.
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2 | BALLOON UNCROSSABLE LESIONS
2.1 | First line strategies
2.1.1 | Guide catheter support
The use of a supportive guide catheter can be the difference between
success and failure. Active and passive support can be increased by
selecting different shaped guides or those with larger diameters (7Fr or
8Fr). Supportive guiding catheters utilize back up support from the con-
tralateral wall of the aorta and help with coaxial alignment to the coronary
arteries.3 Deep engagement of the guide catheter into the coronary artery
helps to provide active support, although as catheter size increases there
is potential for complications from dissection and pressure damping.3
In the senior author's practice and in cases of CTO or calcified
and tortuous arteries, it is the norm to use 7Fr or 8Fr (for CTO cases)
right from the start. The senior author's moto for trainees is “you want
to be fighting with one thing and one thing only and that is the lesion,
guide support is paramount.”
2.1.2 | Balloon selection
Adequate lesion preparation requires an expanded noncompliant
(NC) balloon sized 1:1 with the arterial diameter. Low-profile semi-
compliant (0.85–1.5 mm in diameter) balloons with lubricious coatings
and low crossing profiles should first be utilized before a lesion is
deemed uncrossable. Examples include the 1.0 mm Sapphire Pro
(Orbus Neisch), 1.2 mm Mini-Trek (Abbott Vascular), 0.85 mm Nano
(Vascular Perspectives), Sprinter Legend (Medtronic), Across CTO
(Acrostak), Apex Push (Boston Scientific), and Chocolate (Teleflex) bal-
loons. Oscillating the balloon in a forward and backward motion is a
technique based upon the physical principle that dynamic friction is
less than static friction and may help with crossing resistant lesions.
A new ultralow profile balloon for resistant uncrossable lesions
particularly in CTO PCI has been introduced, the Blimp balloon
(Abbott Vascular). However, limited experience exists so far.
2.1.3 | Guide catheter extensions
Guide catheter extensions permit deep intubation and reach into the
coronary artery and facilitate a smooth pathway to the lesion, travers-
ing calcification and tortuosity in the proximal artery. This increases
support and push at highly resistant lesions increasing the chances of
crossing and successful lesion preparation. Many devices with subtle
design enhancements are available including the Heartrail II (Terumo)
which is an over the wire (OTW) catheter, Guideliner (Vascular Solu-
tions), Guidezella (Boston Scientific), and the Telescope (Medtronic).
Previous publications have supported the use of guide catheter
extensions to enhance lesion crossability with two case series using
the Guideliner device reporting 93% device success rate when used in
cases with tortuous and calcified anatomy.4
In cases of difficult delivery of the guide extension catheters, a
method called “inchworm technique” can be used. It works by inflating
the balloon immediately distal to the guide extender than pulling the
extender over as the balloon is deflated. This is usually is the most
efficient way to advance the guide extender. Alternatively, a balloon
can be inflated distally and the Guide Extender advanced with the bal-
loon inflated (anchor technique).
2.1.4 | Wire-based support techniques
The use of an extra supportive wire is important when dealing with
these cases and can help overcome the problem. A specialty wire, the
Wiggle wire (Abbott Vascular) that has several bends in its body proxi-
mal to the tip can be an option. It works by shifting the direction of
the pushing forces thus “stepping over” the obstacle and pushing the
balloon or stent away from the arterial wall and facilitating delivery.
The Buddy wire technique involves passing a second wire
through the lesion in order to enhance support. This can help to
straighten tortuous bends and reduce friction from wire bias. An
extension of this technique is the use of a second wire to modify
resistant lesions in the so-called wire cutting technique as described
by Hu et al.5 In this process, two coronary guidewires are passed into
the distal vessel and a balloon advanced to the site of the lesion abut-
ting the uncrossable segment. The balloon is then inflated, jailing the
second guidewire between the balloon and the lesion; this guidewire
is then rapidly withdrawn producing a cutting effect and modifying
the lesion to facilitate balloon crossing.
2.1.5 | Anchoring techniques
Anchor balloon support techniques offer additional support by inflat-
ing a balloon in a proximal side branch to enhance guide catheter sta-
bility and alignment. Appropriate sizing of the anchor balloon is crucial
to prevent side-branch dissection or perforation.6-8 An optimal anchor
balloon needs to be large enough not to slip.
Similarly, a wire can be used as an anchor by positioning it in a
side branch which helps to stabilize the guide catheter and offer some
support albeit not as efficient as an anchor balloon. An extra support-
ive wire is always advisable whenever an anchor wire or balloon is
used alone. A guide catheter extension and an anchor balloon can also
be used with two French discrepancies (i.e., 8Fr with 6Fr or less).
2.1.6 | Microcatheters
Microcatheters offer a tapered pushable device with the ability to
transmit torque into and beyond resistant lesions. This can create a
small channel through which small, and subsequently larger, balloons
can be passed. Coiled microcatheters in particular need to be spun
quickly in order to reduce friction in the proximal vessel and to build
up torque helping to cross-resistant lesions. Depending on task at
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hand, a range of microcatheters with differing design properties are
available including Tornus (Asahi Intecc), Corsair, (Asahi Intecc), Fin-
ecross (Terumo), Turnpike, Turnpike LP, Turnpike Spiral, Turnpike
Gold (Teleflex), and Mamba (Boston Scientific). The Tornus catheter is
a metal exchange penetration catheter comprising eight individual
larger wires stranded together to form a spiral (0.12 mm in Tornus
(2.1F) and 0.18mmm in Tornus 88Flex (2.6F).9 This results in a highly
pushable device making it useful in calcified lesions, while the thicker
wires, higher tip stiffness and screw pitch design of the Tornus 88Flex
makes it a more forceful, penetrating microcatheter. Its contribution
to case completion by enhancing lesion crossing has been established
in multiple small case series.10 The Corsair and Caravel microcatheters
(Asahi Intecc) are hybrid microcatheter/septal dilators useful for
antegrade and retrograde CTO PCI.11 The “Shinka” shaft of the Cor-
sair microcatheter is made of 2 larger (0.12 mm) stainless steel wires
wrapped around eight smaller (0.07 mm) wires allowing pushability
and transmission of force, along with flexibility. The braided spiral
structure allows bidirectional rotation while advancing this tapered,
low profile microcatheter.
The Turnpike family of microcatheters (Turnpike, Turnpike Spiral,
Turnpike LP, Turnpike Gold) use a unique multilayered shaft to
enhance torque, flexibility and tracking whilst the hydrophilic coating
over the distal 60 cm enhances lubricity.12 The Turnpike Spiral has a
soft nylon outer coil on the distal 2 cm of shaft which provides rota-
tional assistance for forward progression through lesions when
rotated clockwise. The Turnpike Gold has a threaded metal tip
enhancing penetrative capability by screwing through resistant
lesions.
2.2 | Second line strategies
2.2.1 | Balloon-assisted microdissection
If the proximal cap is “uncrossable” with low-profile balloons despite
the use of enhanced guide catheter and wire support, balloon-assisted
microdissection can allow devices to penetrate the cap or facilitate
subintimal access.13 This technique involves advancing the balloon
tightly against the lesion and intentionally rupturing it adjacent to the
lesion, which can create microdissections around or into lesion. This
can modify the morphology of the lesion or create microdissections,
which in turn can allow another balloon to pass or makes subintimal
entry possible, thus bypassing the resistant lesion in the subintimal
space and allowing reentry distal to the lesion. This technique is easy
to perform and low in cost with a small case series suggesting up to
50% success rate.13 There is a small risk of staining or perforation with
this technique.
2.2.2 | Excimer laser coronary atherectomy
Excimer laser coronary atherectomy (ELCA) utilizes a directional beam
of monochromatic (single wavelength) light and heat energy to modify
plaque by photochemical (fracture of molecular bonds), photothermal
(tissue vaporization), and photokinetic (clearance of by-products)
mechanisms. The prominent mechanism that affects calcium is mainly
the photoacoustic which creates fractures in the calcium and facilitate
lesion preparation. The laser machine emits energy with a fluence
between 30 and 80 mJ/mm2 and a repetition rate of 25–80 pulses/s
through a multitude of catheters ranging in size from 0.9 to 2.0 mm in
diameter. ELCA is performed under continuous saline infusion. In
highly resistant lesions, activation in contrast potentiates the forma-
tion of larger bubbles to modify plaque but is associated with
increased risk of perforation.14,15
2.2.3 | High-speed rotational atherectomy and
orbital atherectormy
High-speed rotational atherectomy (HSRA) is fundamental to facilitate
lesion debulking and crossing where balloons will not track.16 Thinning
of the calcium with HSRA that allows its fracture with dilatation is
thought to be the mechanism of action. The ROTABLATOR system and
ROTAPRO (Boston Scientific) offer burr sizes from 1.25 to 2.50 mm for
calcium modification on a 0.00900 stainless steel wire. Utilizing HSRA to
modify calcific plaque and incite fractures within the calcium to enable
lesion expansion is the preferred strategy prior to stent implantation. It
does, however, require the 0.00900 wire to be passed distally which on
occasion can be challenging in uncrossable lesions.
Orbital atherectormy (OA), where available, is another way of
overcoming this type of lesions once crossed by a wire.17 In Europe
OA is not currently in clinical use while it is available in North America
and other countries.
Combining ELCA and HRSA (also known as RASER angioplasty)
has also been reported for use in lesions where ELCA cannot fully
debulk in isolation but creates a “pilot hole” that facilitates passage of
RotaWire either independently or via microcatheter exchange to per-
mit subsequent HRSA and procedural success.18
2.3 | Third line strategies
2.3.1 | Dissection reentry: The subintimal
approach
If a lesion remains truly uncrossable then the final option would be to
go around it. This means entry to the subintimal space and modifica-
tion of the lesion from the outside.
A wire is left in the true lumen to help minimize the risk of vessel
occlusion and ischemia and it can be used as a landmark for reentry.
Access to the subintimal space can be gained by a “scratch and go”
technique where a stiff wire is used to penetrate into the subintimal
space followed by a softer wire which can knuckle or track around the
lesion. Access to the subintimal space can also come from balloon-
assisted subintimal entry procedure where a balloon sized 1:1 with
the reference diameter of the vessel is inflated proximal to the
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lesion.19 This balloon incites dissections which act as an entry point to
the subintimal space. From here wires, and subsequently balloons, can
be passed around the lesion and reenter the distal true lumen. This
allows modification of the uncrossable lesion from a different per-
spective, often crushing and distorting it from the outside. Once mod-
ified, access to the distal true lumen can be regained with a stiff wire
or the dedicated stingray reentry balloon and the lesion stented in the
usual fashion.
This approach should be a last resort and only performed by
experienced CTO operators.
3 | THE UNDILATABLE LESIONS
Once the lesion has been crossed, it is essential to get adequate lesion
preparation prior to stent implantation. Stent deployment prior to
effective lesion preparation leaves limited and challenging therapeutic
interventions to achieve a good final result if the stent remains under
expanded. Luminal dimensions and minimal stent area are important
factors in determining long-term incidence of in-stent restenosis (ISR)
and stent thrombosis.20-21 In a similar approach to crossing
uncrossable lesions, a step wise approach to lesion modification
should be utilized beginning with the least invasive strategy.
3.1 | NC balloons
NC balloons allow transmission of high pressures to resistant lesions
without change in volume, therefore focusing the pressure within the
lesion rather than transmitting it to other parts of the artery as can hap-
pen with semicompliant balloons. Balloon dilatation is limited in eccen-
tric calcific plaque as guidewire bias may direct transmission of force
away from the calcified segment or due to eccentric dilatation due to
segmental compliance. Despite this transmission of high pressure, many
lesions fail to dilate and require more aggressive strategies.22
On occasions, inflating two smaller size balloons in the lesion
simultaneously can produce a positive outcome or inflating a 1/1 size
balloon to high pressure then reducing and then inflating it again in an
oscillating manner can work too (personal experience).
We recommend the use of shorter NC balloons which help to
focus the applied pressure.
3.2 | Ultrahigh-pressure NC balloons
Ultrahigh-pressure balloons can deliver pressures of up to 40 atm. The
OPN balloon (SIS Medical, Switzerland) has a unique twin layer balloon
construction allowing transmission of super high pressure with a low
incidence of balloon rupture (factory tested rated burst pressure
42 atm). Although seemingly aggressive and intuitively may increase
the risk of perforation, their safety and efficacy have been established
with a low incidence of complications.23 Deliverability of the bulky twin
layer balloon means that its utility in crossing resistant lesions is limited.
3.3 | Cutting/scoring balloons
Cutting balloons consist of OTW or monorail NC balloons with
atherotomes (microsurgical blades) mounted longitudinally along the
surface. The Wolverine coronary cutting balloon (Boston Scientific,
Marlborough, MA) is available in size 2.00–3.25 mm (balloon diameter
models with three atherotomes) or 3.5–4.0 mm (balloon with four
atherotomes) which cut into plaque creating initiation sites for crack
propagation. The atherotomes have the advantage of anchoring into
the intima, preventing slippage frequently seen with focal short
lesions and ISR.24
Scoring balloons consist of balloon mounted spiral scoring wires
designed to anchor into fibrocalcific plaque. The AngioSculpt RX
(Spectranetics, Colorado Springs, CO) is composed of a semicompliant
balloon surrounded by three nitinol spiral scoring wires. It has a lower
crossing profile than OPN ultra high-pressure balloons or cutting bal-
loons and is associated with an increased luminal gain compared to
lesion preparation with NC balloons alone.25
While cutting balloons and scoring balloons should preferentially
be used in plaque modification prestent implantation, they can also be
used to improve stent expansion post stent deployment, and are a
useful adjunct in treating ISR.26
3.4 | Excimer laser coronary atherectomy
Similar to enhancing lesion crossing, excimer laser can be used to
modify undilatable lesions through photothermal, photochemical and
photomechanical disruption of resistant plaque. After modification of
the underlying plaque with ELCA, balloon dilatation with a NC balloon
sized 1:1 with the lumen diameter should be used to ensure adequate
lesion expansions. Excimer laser with and without contrast for the
management of under expanded stents is a safe and viable method to
achieve adequate stent expansion in underexpanded stents that are
usually the result of deploying a stent in an undilatable and poorly
prepared lesions.27,28
3.5 | Rotational atherectomy
HSRA is a fundamental technique to enhance lesion crossing as a
debulking device. Debulking and fracturing heavy calcification
enhances lesion crossing and expansion. Balloon dilatation with a NC
balloon sized 1:1 with the artery is essential following HSRA to ensure
effective calcium modification, fracture and lesion expansion prior to
stent implantation.
3.6 | Intravascular lithotripsy
Intravascular lithotripsy (IVL) uses a series of electrohydraulic litho-
tripsy emitters housed within a balloon to create ultrasonic pressure
waves which dissipate through calcific plaque causing fractures. The
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shockwave IVL system (Shockwave Medical Inc., Fremont, CA) is avail-
able in balloon sized 2.5–4.0 mm and 12 mm length and balloons should
be sized 1:1 with the vessel reference diameter. The balloon catheter is
then connected to a generator which delivers 10 pulses of ultrasonic
energy over 10 s, up to a maximum of eight cycles per balloon. IVL
works best with a circumferential arc of calcium (>2700) as the ultra-
sonic waves reverberate to cause fractures in calcium. After delivering
the IVL and if the balloon has fully expanded, then it is not uniformly
recommended to follow on with a predilatation balloon. However, many
operators use an NC balloon for optimal lesion expansion. In the DIS-
RUPT CAD I trial (ClinicalTrials.gov, number NCT02650128) calcified
lesions pretreated with IVL had reduced residual stenosis and multiple
fracture lines in calcific plaque on OCT without any MACE.29 It is easy
to use, has a low crossing profile especially in comparison to OPN and
cutting balloons and has very few side effects.
Figure 1 demonstrates an algorithm of the techniques that can be
used in resistant lesions.
4 | CONCLUSION
Balloon uncrossable lesions are commonly encountered during routine
and CTO PCI and are a potential barrier to successful revasculariza-
tion. Employing basic principles in guide catheter support and adjunc-
tive techniques for crossing resistant lesions increases the likelihood
of successful lesion crossing. Once a balloon can cross a lesion, the
lesion must be adequately prepared and expanded prior to stent
implantation.
Undilatable lesions pose a further challenge to obtaining optimal
stent expansion which can result in ISR and stent thrombosis. Utilizing
advanced techniques and embracing new technological advances is
key to adequately preparing and debulking lesions in order to get the
best stent results and outcomes for patients.
It is important to emphasize that these techniques are inter-
changeable and can be used in any order depending on availability
and operator experience to help achieve a successful PCI outcome.
- Small low profile balloon <1.5mm
- Increase guide catheter support 
 Large calibre 
More supportive shape 
- Buddy wire, wire cutting 
- Guide extension 
- Anchoring, wire or balloon 
- Microcatheters
 Corsair/ caravel/ Turnpike/ Tornus 
- If one fails, try another device with extra 
crossing capability, Turnpilke Gold/ Tornus 
- Balloon assisted micro-dissection, BAM
- ELCA, LASER 
- Rotablation, Orbital atherectomy (where  
   Available) 
- RASER (Laser & Rotablation) 
- Intra-vascular Lithotripsy 
- Subintimal approach
 - Dissection re-entry 
 - Subintimal anchor 
 - Retrograde balloon anchor in CTO cases 
In isolation or
a combinations 
2nd Line 
3rd Line 
1st Line 
F IGURE 1 An algorithm for
approaching uncrossable,
undilatable resisitant coronary
lesions. techniques can be used in
isolation or in combination
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